Efficacy News and Research

RSS
Bioton and Actavis form joint venture

Bioton and Actavis form joint venture

Takeda returns POSIDUR development and commercialization rights to DURECT

Takeda returns POSIDUR development and commercialization rights to DURECT

HSP40/70 linked to hepatitis C infection

HSP40/70 linked to hepatitis C infection

UMC to offer ditto device for pediatric patients

UMC to offer ditto device for pediatric patients

Juventas' JVS-100 Phase I heart failure trial meets primary safety endpoint

Juventas' JVS-100 Phase I heart failure trial meets primary safety endpoint

End alternative medicine degrees say scientists

End alternative medicine degrees say scientists

FDA approves Baxter's TISSEEL for general hemostasis in surgery

FDA approves Baxter's TISSEEL for general hemostasis in surgery

FDA approves Medtronic DF4 High-Voltage Connector System for ICDs and CRT-Ds

FDA approves Medtronic DF4 High-Voltage Connector System for ICDs and CRT-Ds

Workshop on psychodrama therapy efficacy at iaedp Symposium 2012

Workshop on psychodrama therapy efficacy at iaedp Symposium 2012

Susan Mallery finds breakthrough treatment for oral cancer

Susan Mallery finds breakthrough treatment for oral cancer

Scientists develop new vaccine to treat cancer at pre-clinical level

Scientists develop new vaccine to treat cancer at pre-clinical level

New system safe, effective in delivering CsA to organ transplant patients

New system safe, effective in delivering CsA to organ transplant patients

FDA approves UCB's Keppra for treatment of partial onset seizures in infants

FDA approves UCB's Keppra for treatment of partial onset seizures in infants

Amorcyte commences enrollment in PreSERVE Phase 2 trial for acute myocardial infarction

Amorcyte commences enrollment in PreSERVE Phase 2 trial for acute myocardial infarction

UH Case Medical Center initiates enrollment in Moxy Drug Coated Balloon trial for PAD

UH Case Medical Center initiates enrollment in Moxy Drug Coated Balloon trial for PAD

One-year results from Covidien's EverFlex stent trial on P.A.D.

One-year results from Covidien's EverFlex stent trial on P.A.D.

Sofie to receive U.S. patent for novel PET probes

Sofie to receive U.S. patent for novel PET probes

IHS experts develop new guidelines for migraine clinical trials

IHS experts develop new guidelines for migraine clinical trials

Aphios receives NIH's Phase II SBIR grant to develop APH-0703 for AD

Aphios receives NIH's Phase II SBIR grant to develop APH-0703 for AD

Genoscience, BioLineRx to develop and commercialize BL-8020 for HCV

Genoscience, BioLineRx to develop and commercialize BL-8020 for HCV

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.